These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 17079238
1. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model. Zhanel GG, Derkatch S, Laing N, Noreddin AM, Hoban DJ. J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238 [Abstract] [Full Text] [Related]
6. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model. Zhanel GG, Yachison C, Nichol K, Adam H, Noreddin AM, Hoban DJ, Karlowsky JA. J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630 [Abstract] [Full Text] [Related]
9. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation. Sevillano D, Calvo A, Giménez MJ, Alou L, Aguilar L, Valero E, Carcas A, Prieto J. J Antimicrob Chemother; 2004 Dec; 54(6):1148-51. PubMed ID: 15489246 [Abstract] [Full Text] [Related]
11. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae. Knudsen JD. Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659 [Abstract] [Full Text] [Related]
12. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. Brown SD, Rybak MJ. J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831 [Abstract] [Full Text] [Related]
15. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin]. Fenoll A, Robledo O, Lerma M, Giménez MJ, Cebrián L, Casal J, Aguilar L, Gómez-Lus ML. Rev Esp Quimioter; 2006 Mar; 19(1):39-44. PubMed ID: 16688290 [Abstract] [Full Text] [Related]
16. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation. Sevillano D, Alou L, Aguilar L, Echevarría O, Giménez MJ, Prieto J. J Antimicrob Chemother; 2006 Jun; 57(6):1128-33. PubMed ID: 16617063 [Abstract] [Full Text] [Related]
17. AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model. Zelenitsky SA, Ariano RE, Iacovides H, Sun S, Harding GK. J Antimicrob Chemother; 2003 Apr; 51(4):905-11. PubMed ID: 12654762 [Abstract] [Full Text] [Related]
19. Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens. Odenholt I, Cars O, Löwdin E. J Antimicrob Chemother; 2004 Dec; 54(6):1062-6. PubMed ID: 15563517 [Abstract] [Full Text] [Related]